Anna Protopapas, President & CEO: Mersana Therapeutics MRSN Sell · Filed 23/01/18

Trade details

Type: Insider sale
Amount: $99,566.04
Shares · price: 17,346 sh · $5.74 a share
Held after: 48,733 sh
Stock: Mersana Therapeutics MRSN
Person: Anna ProtopapasPresident & CEO
Trade date: 23/01/17
Filed: 23/01/18
Days to filing: 1 days

Sold 26.3% of holdings

Share of holding sold: 26.3%

Mersana Therapeutics trades, last 26 weeks

What else happened in Mersana Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/18~23/02/16

Anna Protopapas's recent trades

Anna ProtopapasDirector
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$5,009
8,637 sh
$5,009
Filed 25/01/17
Traded 25/01/16
Anna ProtopapasDirector
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$3,900
6,191 sh
$3,900
Filed 25/01/16
Traded 25/01/15
Anna ProtopapasDirector
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$7,612
11,534 sh
$7,612
Filed 25/01/15
Traded 25/01/14
Anna ProtopapasDirector
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$79.7K
29,399 sh
$79.7K
Filed 24/01/17
Traded 24/01/16
Anna ProtopapasDirector
SellNuvalent
Sell
Nuvalent
NUVL
$378.4K
5,000 sh
$378.4K
Filed 23/12/20
Traded 23/12/18